Regulation of bone morphogenetic protein signalling in human pulmonary vascular development
暂无分享,去创建一个
R. Trembath | N. Morrell | M. Southwood | P. Upton | S. Stewart | S. Haworth | L. Long | Xudong Yang | C. Atkinson | T. Jeffery | R. Trembath | N. Morrell | X. Yang | P. Upton | TK Jeffery | SM Hall | PN Reynolds | Susan M. Hall | Carl Atkinson | Sheila G. Haworth | Susan Stewart | Paul N. Reynolds
[1] J. Klingensmith,et al. The Bone Morphogenetic Protein Antagonist Noggin Regulates Mammalian Cardiac Morphogenesis , 2007, Circulation research.
[2] W. Seeger,et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[3] D. Stewart,et al. Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension , 2006, Circulation research.
[4] D. Warburton,et al. Smad1 expression and function during mouse embryonic lung branching morphogenesis. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[5] N. Rudarakanchana,et al. Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension , 2005, Circulation research.
[6] R. Trembath,et al. BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[7] A. Zaiman,et al. Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.
[8] K. Miyazono,et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[9] J. Knowles,et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease , 2004, European Respiratory Journal.
[10] D. Warburton,et al. Overexpression of Smurf1 negatively regulates mouse embryonic lung branching morphogenesis by specifically reducing Smad1 and Smad5 proteins. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[11] K. Brown,et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. , 2003, The New England journal of medicine.
[12] K. Miyazono,et al. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. , 2003, Molecular biology of the cell.
[13] M. Shibuya,et al. Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression , 2003, Molecular and Cellular Biology.
[14] B. Hogan,et al. Tissue interactions pattern the mesenchyme of the embryonic mouse lung. , 2003, Developmental biology.
[15] K. Lyons,et al. BMP signaling is required for septation of the outflow tract of the mammalian heart , 2003, Development.
[16] M. Goumans,et al. Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells , 2002, Circulation.
[17] R. Trembath,et al. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor , 2002, Circulation.
[18] Susan M Hall,et al. Origin, differentiation, and maturation of human pulmonary veins. , 2002, American journal of respiratory cell and molecular biology.
[19] C. Heldin,et al. Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.
[20] M. Asashima,et al. Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis † , 2001, Development, growth & differentiation.
[21] R. Kim,et al. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. , 2001, Developmental biology.
[22] M. Humbert,et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.
[23] C. Fischer,et al. Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene , 2000, Circulation.
[24] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[25] A. Hislop,et al. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. , 2000, American journal of respiratory cell and molecular biology.
[26] K. Miyazono,et al. BMP type II receptor is required for gastrulation and early development of mouse embryos. , 2000, Developmental biology.
[27] David Warburton,et al. The molecular basis of lung morphogenesis , 2000, Mechanisms of Development.
[28] H. Baldwin,et al. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. , 2000, American journal of respiratory cell and molecular biology.
[29] M. Yacoub,et al. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[30] Jeffrey L. Wrana,et al. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.
[31] D. Warburton,et al. Molecular embryology of the lung: then, now, and in the future. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[32] C. Deng,et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. , 1999, Development.
[33] M. Whitman. Smads and early developmental signaling by the TGFbeta superfamily. , 1998, Genes & development.
[34] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[35] B. Hogan,et al. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. , 1996, Development.
[36] H. Baldwin. Early embryonic vascular development. , 1996, Cardiovascular research.
[37] K. Lyons,et al. A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. , 1994, Biochemical and biophysical research communications.
[38] G. Simonneau,et al. Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.
[39] J. Markham,et al. Pulmonary angiotensin-converting enzyme (ACE) binding and inhibition in humans. A positron emission tomography study. , 2000, American journal of respiratory and critical care medicine.
[40] P. Burri. Lung Development and Pulmonary Angiogenesis , 1999 .
[41] P. Hufnagl,et al. Alpha-smooth muscle actin distribution in the pulmonary vasculature comparing hypoplastic and normal fetal lungs. , 1998, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.
[42] K. Miyazono,et al. Receptors for transforming growth factor-beta. , 1994, Advances in immunology.
[43] J. Thiery,et al. † Author for correspondence , 1693 .